Stock KYTX KYVERNA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Kyverna Therapeutics, Inc.

Equities

KYTX

US5019761049

Market Closed - Nasdaq
Other stock markets
 01:30:00 25/05/2024 am IST 		5-day change 1st Jan Change
13 USD +4.59% Intraday chart for Kyverna Therapeutics, Inc. -15.69% 0.00%
14/05 Kyverna Therapeutics Q1 Loss Narrows MT
25/04 Nasdaq's revenue beats on strong demand for fintech products RE

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kyverna Therapeutics Q1 Loss Narrows
Nasdaq's revenue beats on strong demand for fintech products
Kyverna Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Sector Update: Health Care Stocks Steady Pre-Bell Friday
Kyverna Therapeutics and Stanford University Agree to Evaluate KYV-101 in Patients with Non-Relapsing and Progressive Forms of Multiple Sclerosis
Moderna, Bayer-backed Metagenomi stock drops 32% on Nasdaq debut
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KYTX Stock
  4. News Kyverna Therapeutics, Inc.
  5. Other languages